The Business of Fashion
Agenda-setting intelligence, analysis and advice for the global fashion community.
Agenda-setting intelligence, analysis and advice for the global fashion community.
Brazilian cosmetics maker Natura & Co expects its accounts to improve in the second half of the year after a soft start to 2023, executives said on Tuesday, with a cash boost scheduled from the sale of its Aesop brand and strategic changes.
Natura on Monday posted a net loss of 732 million reais, narrowing its year-ago loss but the company said its still faces “high financial expenses.”
It added this would be addressed upon closing its sale of Australian luxury brand Aesop scheduled for the third quarter, having agreed to a $2.53 billion deal in April with French cosmetics group L’Oréal.
“(Natura’s leveraging issue) will be solved by Q3,” chief financial officer Guilherme Castellan told reporters on Tuesday, adding that the company would address its debt payments in the fourth quarter.
ADVERTISEMENT
The company also expects to invest in advertising and store restructuring in some countries as part of its operations revamp.
In addition, Natura plans to expand its brand integration programme — bringing together Natura and Avon brands under the same sales teams — to Brazil in the coming weeks.
“(We will start integration) in other countries in 2024,” Natura’s CEO in Latin America, Joao Paulo Ferreira, said.
By Carolina Pulice, Editor: Matthew Lewis
Learn more:
Brazilian Beauty Giant Natura Proposes 32 Percent Cut to Management Pay
The Sao Paulo-based company’s board proposed setting the total remuneration of its senior managers at about 78 million reais ($15 million) for the 12 months starting in May, down from the 115 million reais initially proposed for the same period a year earlier, according to a regulatory filing Monday.
The showcase translated the company’s global insights consumer study into scent profiles, technologies and fragrances.
The Estée Lauder-owned premium fragrance house has signed a two-year deal with the actor in a bet to seize more of the men’s market.
From medspas to telemedicine, weight loss drugs are becoming adopted for mainstream cosmetic use.
Mature consumers have long been ignored by the beauty industry. Now a small but growing number of emerging brands are responding to the needs of those over the age of 45 in a bid to cash in on their $15 trillion spending power.